Biodegradable PLGA microparticles for sustained release of a new GnRH antagonist: part II. In vivo performance
- 31 May 2004
- journal article
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 57 (3) , 441-446
- https://doi.org/10.1016/j.ejpb.2004.01.005
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Biodegradable microparticles for sustained release of a new GnRH antagonist – part I: screening commercial PLGA and formulation technologiesEuropean Journal of Pharmaceutics and Biopharmaceutics, 2003
- GnRH Antagonists: A New Generation of Long Acting Analogues Incorporatingp-Ureido-phenylalanines at Positions 5 and 6Journal of Medicinal Chemistry, 2000
- Evaluation of orntide microspheres in a rat animal model and correlation to in vitro release profilesAAPS PharmSciTech, 2000
- Development of GnRH Antagonists for Prostate Cancer: New Approaches to TreatmentThe Oncologist, 2000
- Biodegradation and biocompatibility of PLA and PLGA microspheresPublished by Elsevier ,1999
- One- and three-month release injectable microspheres of the LH-RH superagonist leuprorelin acetateAdvanced Drug Delivery Reviews, 1997
- Physicochemical properties of A-75998, an antagonist of luteinizing hormone releasing hormoneJournal of Pharmaceutical Sciences, 1995
- Nano- and microparticles for the delivery of polypeptides and proteinsAdvanced Drug Delivery Reviews, 1993
- Parenteral Peptide Formulations: Chemical and Physical Properties of Native Luteinizing Hormone-Releasing Hormone (LHRH) and Hydrophobic Analogues in Aqueous SolutionPharmaceutical Research, 1991